NO20014012L - Inhibitorer for anvendelse i hemostase og immunfunksjon - Google Patents

Inhibitorer for anvendelse i hemostase og immunfunksjon

Info

Publication number
NO20014012L
NO20014012L NO20014012A NO20014012A NO20014012L NO 20014012 L NO20014012 L NO 20014012L NO 20014012 A NO20014012 A NO 20014012A NO 20014012 A NO20014012 A NO 20014012A NO 20014012 L NO20014012 L NO 20014012L
Authority
NO
Norway
Prior art keywords
hemostasis
inhibitors
immune function
related protein
complement related
Prior art date
Application number
NO20014012A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014012D0 (no
Inventor
Paul O Sheppard
Gerald W Lasser
Paul D Bishop
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of NO20014012D0 publication Critical patent/NO20014012D0/no
Publication of NO20014012L publication Critical patent/NO20014012L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20014012A 1999-02-19 2001-08-17 Inhibitorer for anvendelse i hemostase og immunfunksjon NO20014012L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25360499A 1999-02-19 1999-02-19
US44479499A 1999-11-22 1999-11-22
PCT/US2000/004161 WO2000048625A2 (en) 1999-02-19 2000-02-17 Inhibitors for use in hemostasis and immune function

Publications (2)

Publication Number Publication Date
NO20014012D0 NO20014012D0 (no) 2001-08-17
NO20014012L true NO20014012L (no) 2001-10-02

Family

ID=26943406

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014012A NO20014012L (no) 1999-02-19 2001-08-17 Inhibitorer for anvendelse i hemostase og immunfunksjon

Country Status (20)

Country Link
US (1) US6448221B1 (de)
EP (2) EP1382345A3 (de)
JP (1) JP2002537270A (de)
KR (1) KR20010102130A (de)
CN (1) CN1341027A (de)
AT (1) ATE245439T1 (de)
AU (1) AU772103B2 (de)
BR (1) BR0008298A (de)
CA (1) CA2361273A1 (de)
CZ (1) CZ20012916A3 (de)
DE (1) DE60004015T2 (de)
DK (1) DK1154785T3 (de)
ES (1) ES2202061T3 (de)
HK (1) HK1039892A1 (de)
HU (1) HUP0105284A3 (de)
IL (1) IL144460A0 (de)
NO (1) NO20014012L (de)
PL (1) PL349924A1 (de)
PT (1) PT1154785E (de)
WO (1) WO2000048625A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525174B1 (en) 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
US6544946B1 (en) * 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
US20040014650A1 (en) * 2002-07-17 2004-01-22 Sheppard Paul D Methods for enhancing wound repair
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
MY128992A (en) * 2000-08-25 2007-03-30 Merck Patent Gmbh Saratin for inhibiting platelet adhesion to collagen
WO2002026139A1 (en) 2000-09-29 2002-04-04 Cordis Corporation Coated medical devices
US20030220253A1 (en) * 2002-03-08 2003-11-27 Lasser Gerald W. Inhibitors for use in hemostasis
NO20035748D0 (no) * 2003-12-19 2003-12-19 Amersham Health As Optisk avbildning av sårbar arteriosklerose
RU2279853C2 (ru) * 2004-07-23 2006-07-20 Наталья Юрьевна Демидова Способ коррекции нарушений гемостаза при обширных операциях на органах гепатопанкреатодуоденальной зоны
US9471978B2 (en) 2004-10-04 2016-10-18 Banner Health Methodologies linking patterns from multi-modality datasets
WO2006104964A2 (en) * 2005-03-28 2006-10-05 University Of Louisville Research Foundation, Inc. Inhibition of wet type age related macular degeneration (amd) by adiponectin or acrp 30
AU2006275006A1 (en) * 2005-07-29 2007-02-08 Merck Serono Sa Use of the globular domain of Acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases
EP2103627B1 (de) 2006-12-21 2015-09-02 JNC Corporation Verfahren zur Induktion der Thrombozytenaggregation
JP5747370B2 (ja) * 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
WO2023215294A1 (en) * 2022-05-02 2023-11-09 The Board Of Trustees Of The Leland Stanford Junior University Complement pathway inhibition for wound healing

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) * 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
JP2002513295A (ja) 1997-07-08 2002-05-08 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド １２３種類のヒト分泌タンパク質
US6265544B1 (en) 1997-07-18 2001-07-24 Zymogenetics, Inc. Adipocyte-specific protein homologs
PT1000149E (pt) 1997-08-01 2007-08-03 Serono Genetics Inst Sa 5' ests para proteínas segregadas identificadas a partir de tecidos do cérebro.
CA2301660A1 (en) 1997-08-26 1999-03-04 Zymogenetics, Inc. Adipocyte-specific protein homologs
JP3538711B2 (ja) 1997-10-29 2004-06-14 大塚製薬株式会社 平滑筋増殖抑制組成物、動脈硬化症診断方法及びそのキット
NZ522634A (en) 1997-12-03 2004-02-27 Genentech Inc PRO243 encoding a polypeptide with homology to chordin and antibodies and vectors
WO1999033979A2 (en) 1997-12-30 1999-07-08 Chiron Corporation Bone marrow secreted proteins and polynucleotides
ID27813A (id) 1998-01-28 2001-04-26 Corixa Corp Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
WO1999055865A1 (en) 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use
EP1085897A4 (de) 1998-05-21 2003-03-12 Smithkline Beecham Corp Acrp30r1l, ein homologes zu acrp30 (30 kd adipozyten komplement verwandtes protein)

Also Published As

Publication number Publication date
EP1382345A2 (de) 2004-01-21
WO2000048625A2 (en) 2000-08-24
PL349924A1 (en) 2002-10-21
AU772103B2 (en) 2004-04-08
NO20014012D0 (no) 2001-08-17
ES2202061T3 (es) 2004-04-01
CA2361273A1 (en) 2000-08-24
ATE245439T1 (de) 2003-08-15
JP2002537270A (ja) 2002-11-05
CN1341027A (zh) 2002-03-20
US6448221B1 (en) 2002-09-10
WO2000048625A3 (en) 2000-12-28
DE60004015D1 (de) 2003-08-28
AU2883200A (en) 2000-09-04
DE60004015T2 (de) 2004-04-15
HUP0105284A2 (hu) 2002-05-29
EP1154785A2 (de) 2001-11-21
KR20010102130A (ko) 2001-11-15
CZ20012916A3 (cs) 2002-05-15
IL144460A0 (en) 2002-05-23
HUP0105284A3 (en) 2003-12-29
EP1382345A3 (de) 2004-01-28
PT1154785E (pt) 2003-12-31
BR0008298A (pt) 2002-02-19
DK1154785T3 (da) 2003-11-17
HK1039892A1 (zh) 2002-05-17
EP1154785B1 (de) 2003-07-23

Similar Documents

Publication Publication Date Title
NO20014012D0 (no) Inhibitorer for anvendelse i hemostase og immunfunksjon
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
AU5056196A (en) Hydrogel-forming, self-solvating absorbable polyester copolymers and methods for use thereof
NZ263344A (en) Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
DK1918298T3 (da) Peptid
EA200400632A1 (ru) Пептиды, эффективные в лечении опухолей и других заболеваний, требующих удаления или разрушения клеток
CA2181150A1 (en) Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
DE69432984D1 (de) Therapeutische substituierte guanidine
DE69703689D1 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
IS5591A (is) Grunnmassaprótínsamsetningar til sáragræðslu
NO20013608D0 (no) DNA-klon for human vevsfaktorinhibitor
DE60020681D1 (de) Zusammensetzungen und verfahren zur verbesserung der integrität von angegriffenen körperpassagewegen und höhlen
ITTO20010804A0 (it) Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl
GB9930768D0 (en) Composition
DK0643585T3 (da) Anvendelsen af lipoprotein-associeret koagulationsinhibitor (LACI) til fremstilling af et lægemiddel til behandlingen af ak
PL354961A1 (en) Prevention and treatment of diseases associated with blood coagulation
ATE312179T1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
ID23176A (id) Metoda untuk mengobati gangguan pembuluh darah
DE60139574D1 (de) Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutung
DE50207168D1 (de) Kombinationspräparat zur Therapie von immunologischen Erkrankungen
GEP19991605B (en) Inhibitor, Its Obtaining and Use
UA9703A (uk) Антипротеіназний засіб
UA37445A (uk) Протизапальний засіб